Natixis Gsk PLC Transaction History

Natixis

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $219,753 - $249,646	-5,226 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $210,241 - $249,489	5,226 New	5,226 $228,000
Q3 2020 Nov 12, 2020	SELL	$38.11 - $42.99 $449,316 - $506,852	-11,790 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $446,487 - $513,808	11,790 New	11,790 $481,000
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $624,657 - $939,391	-19,238 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $352,842 - $405,348	8,401 Added 77.52%	19,238 $906,000
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $86,624 - $93,176	2,141 Added 24.62%	10,837 $463,000
Q2 2019 Aug 13, 2019	SELL	$39.4 - $42.7 $650,454 - $704,934	-16,509 Reduced 65.5%	8,696 $348,000
Q1 2019 May 15, 2019	BUY	$38.57 - $42.69 $163,845 - $181,347	4,248 Added 20.27%	25,205 $1.06 Million
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $249,744 - $282,052	-6,607 Reduced 23.97%	20,957 $801,000
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $224,309 - $240,899	5,643 Added 25.74%	27,564 $1.11 Million
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $148,101 - $159,879	3,739 Added 20.56%	21,921 $884,000
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $1.95 Million - $2.16 Million	-53,901 Reduced 74.78%	18,182 $701,000
Q4 2017 Feb 14, 2018	BUY	$35.34 - $41.9 $2.26 Million - $2.68 Million	63,870 Added 777.67%	72,083 $2.56 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $323,920 - $341,250	8,213	8,213 $333,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.